Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
J Neurosci
2009 Nov 04;2944:13898-908. doi: 10.1523/JNEUROSCI.2833-09.2009.
Show Gene links
Show Anatomy links
Main immunogenic region structure promotes binding of conformation-dependent myasthenia gravis autoantibodies, nicotinic acetylcholine receptor conformation maturation, and agonist sensitivity.
Luo J, Taylor P, Losen M, de Baets MH, Shelton GD, Lindstrom J.
???displayArticle.abstract???
The main immunogenic region (MIR) is a conformation-dependent region at the extracellular apex of alpha1 subunits of muscle nicotinic acetylcholine receptor (AChR) that is the target of half or more of the autoantibodies to muscle AChRs in human myasthenia gravis and rat experimental autoimmune myasthenia gravis. By making chimeras of human alpha1 subunits with alpha7 subunits, both MIR epitopes recognized by rat mAbs and by the patient-derived human mAb 637 to the MIR were determined to consist of two discontiguous sequences, which are adjacent only in the native conformation. The MIR, including loop alpha1 67-76 in combination with the N-terminal alpha helix alpha1 1-14, conferred high-affinity binding for most rat mAbs to the MIR. However, an additional sequence corresponding to alpha1 15-32 was required for high-affinity binding of human mAb 637. A water soluble chimera of Aplysia acetylcholine binding protein with the same alpha1 MIR sequences substituted was recognized by a majority of human, feline, and canine myasthenia gravis sera. The presence of the alpha1 MIR sequences in alpha1/alpha7 chimeras greatly promoted AChR expression and significantly altered the sensitivity to activation. This reveals a structural and functional, as well as antigenic, significance of the MIR.
Beroukhim,
Three-dimensional location of the main immunogenic region of the acetylcholine receptor.
1995, Pubmed
Beroukhim,
Three-dimensional location of the main immunogenic region of the acetylcholine receptor.
1995,
Pubmed Brejc,
Crystal structure of an ACh-binding protein reveals the ligand-binding domain of nicotinic receptors.
2001,
Pubmed Castelán,
Cytoplasmic regions adjacent to the M3 and M4 transmembrane segments influence expression and function of alpha7 nicotinic acetylcholine receptors. A study with single amino acid mutants.
2007,
Pubmed
,
Xenbase Castillo,
Role of the N-terminal alpha-helix in biogenesis of alpha7 nicotinic receptors.
2009,
Pubmed
,
Xenbase Conroy,
TE671 cells express an abundance of a partially mature acetylcholine receptor alpha subunit which has characteristics of an assembly intermediate.
1990,
Pubmed
,
Xenbase Conti-Tronconi,
Monoclonal antibodies as probes of acetylcholine receptor structure. 2. Binding to native receptor.
1981,
Pubmed Das,
The main immunogenic region of the nicotinic acetylcholine receptor: interaction of monoclonal antibodies with synthetic peptides.
1989,
Pubmed
,
Xenbase Dellisanti,
Crystal structure of the extracellular domain of nAChR alpha1 bound to alpha-bungarotoxin at 1.94 A resolution.
2007,
Pubmed Engel,
Current understanding of congenital myasthenic syndromes.
2005,
Pubmed Feng,
Rapsyn clusters neuronal acetylcholine receptors but is inessential for formation of an interneuronal cholinergic synapse.
1998,
Pubmed Ficklin,
Ubiquilin-1 regulates nicotine-induced up-regulation of neuronal nicotinic acetylcholine receptors.
2005,
Pubmed Fostieri,
Isolation of potent human Fab fragments against a novel highly immunogenic region on human muscle acetylcholine receptor which protect the receptor from myasthenic autoantibodies.
2005,
Pubmed Gee,
Identification of domains influencing assembly and ion channel properties in alpha 7 nicotinic receptor and 5-HT3 receptor subunit chimaeras.
2007,
Pubmed Gerzanich,
alpha 5 Subunit alters desensitization, pharmacology, Ca++ permeability and Ca++ modulation of human neuronal alpha 3 nicotinic receptors.
1998,
Pubmed
,
Xenbase Graus,
Anti-acetylcholine receptor Fab fragments isolated from thymus-derived phage display libraries from myasthenia gravis patients reflect predominant specificities in serum and block the action of pathogenic serum antibodies.
1997,
Pubmed Gullick,
Mapping the binding of monoclonal antibodies to the acetylcholine receptor from Torpedo californica.
1983,
Pubmed Hansen,
Structural and ligand recognition characteristics of an acetylcholine-binding protein from Aplysia californica.
2004,
Pubmed Hansen,
Structures of Aplysia AChBP complexes with nicotinic agonists and antagonists reveal distinctive binding interfaces and conformations.
2005,
Pubmed Hansen,
Tryptophan fluorescence reveals conformational changes in the acetylcholine binding protein.
2002,
Pubmed Henchman,
Asymmetric structural motions of the homomeric alpha7 nicotinic receptor ligand binding domain revealed by molecular dynamics simulation.
2003,
Pubmed Hurst,
A novel positive allosteric modulator of the alpha7 neuronal nicotinic acetylcholine receptor: in vitro and in vivo characterization.
2005,
Pubmed
,
Xenbase Im,
Role of tolerogen conformation in induction of oral tolerance in experimental autoimmune myasthenia gravis.
2000,
Pubmed Konstantakaki,
Molecular modeling of the complex between Torpedo acetylcholine receptor and anti-MIR Fab198.
2007,
Pubmed Kontou,
The crystal structure of the Fab fragment of a rat monoclonal antibody against the main immunogenic region of the human muscle acetylcholine receptor.
2000,
Pubmed Kuryatov,
Mutation causing autosomal dominant nocturnal frontal lobe epilepsy alters Ca2+ permeability, conductance, and gating of human alpha4beta2 nicotinic acetylcholine receptors.
1997,
Pubmed
,
Xenbase Kuryatov,
Roles of accessory subunits in alpha4beta2(*) nicotinic receptors.
2008,
Pubmed Lennon,
Recombinant human acetylcholine receptor alpha-subunit induces chronic experimental autoimmune myasthenia gravis.
1991,
Pubmed Lindstrom,
Acetylcholine receptors and myasthenia.
2000,
Pubmed Lindstrom,
Antigenic modulation and receptor loss in experimental autoimmune myasthenia gravis.
1979,
Pubmed Lindstrom,
Neuronal nicotinic acetylcholine receptors.
1996,
Pubmed Lindstrom,
Immunization of rats with polypeptide chains from torpedo acetylcholine receptor causes an autoimmune response to receptors in rat muscle.
1978,
Pubmed Mariuzza,
The structural basis of antigen-antibody recognition.
1987,
Pubmed McLane,
Epitope mapping of polyclonal and monoclonal antibodies against two alpha-bungarotoxin-binding alpha subunits from neuronal nicotinic receptors.
1992,
Pubmed
,
Xenbase Merlie,
Assembly in vivo of mouse muscle acetylcholine receptor: identification of an alpha subunit species that may be an assembly intermediate.
1983,
Pubmed Newland,
Functional and non-functional isoforms of the human muscle acetylcholine receptor.
1995,
Pubmed
,
Xenbase Papke,
The correction of alpha7 nicotinic acetylcholine receptor concentration-response relationships in Xenopus oocytes.
1998,
Pubmed
,
Xenbase Peng,
Nicotine-induced increase in neuronal nicotinic receptors results from a decrease in the rate of receptor turnover.
1994,
Pubmed
,
Xenbase Ratnam,
Transmembrane topography of nicotinic acetylcholine receptor: immunochemical tests contradict theoretical predictions based on hydrophobicity profiles.
1986,
Pubmed Reeves,
Structure and function in rhodopsin: high-level expression of rhodopsin with restricted and homogeneous N-glycosylation by a tetracycline-inducible N-acetylglucosaminyltransferase I-negative HEK293S stable mammalian cell line.
2002,
Pubmed Saedi,
Determination of amino acids critical to the main immunogenic region of intact acetylcholine receptors by in vitro mutagenesis.
1990,
Pubmed
,
Xenbase Shelton,
Risk factors for acquired myasthenia gravis in cats: 105 cases (1986-1998).
2000,
Pubmed Shelton,
Canine and human myasthenia gravis autoantibodies recognize similar regions on the acetylcholine receptor.
1988,
Pubmed Shelton,
Spontaneous remission in canine myasthenia gravis: implications for assessing human MG therapies.
2001,
Pubmed Tzartos,
Main immunogenic region of Torpedo electroplax and human muscle acetylcholine receptor: localization and microheterogeneity revealed by the use of synthetic peptides.
1990,
Pubmed Tzartos,
Passive transfer of experimental autoimmune myasthenia gravis by monoclonal antibodies to the main immunogenic region of the acetylcholine receptor.
1987,
Pubmed Tzartos,
Specificities of antibodies to acetylcholine receptors in sera from myasthenia gravis patients measured by monoclonal antibodies.
1982,
Pubmed Tzartos,
Mapping of surface structures of electrophorus acetylcholine receptor using monoclonal antibodies.
1981,
Pubmed Tzartos,
Monoclonal antibodies used to probe acetylcholine receptor structure: localization of the main immunogenic region and detection of similarities between subunits.
1980,
Pubmed Tzartos,
Anatomy of the antigenic structure of a large membrane autoantigen, the muscle-type nicotinic acetylcholine receptor.
1998,
Pubmed Tzartos,
Characteristics of monoclonal antibodies to denatured Torpedo and to native calf acetylcholine receptors: species, subunit and region specificity.
1986,
Pubmed Tzartos,
Demonstration of a main immunogenic region on acetylcholine receptors from human muscle using monoclonal antibodies to human receptor.
1983,
Pubmed Unwin,
Refined structure of the nicotinic acetylcholine receptor at 4A resolution.
2005,
Pubmed van der Neut Kolfschoten,
Anti-inflammatory activity of human IgG4 antibodies by dynamic Fab arm exchange.
2007,
Pubmed Vernino,
Autoantibody profiles and neurological correlations of thymoma.
2004,
Pubmed Wang,
Chronic nicotine treatment up-regulates human alpha3 beta2 but not alpha3 beta4 acetylcholine receptors stably transfected in human embryonic kidney cells.
1998,
Pubmed
,
Xenbase
